Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Stephen W. Hildreth"'
Autor:
Michael Nguyen, Katherine Fries, Rawia Khoury, Lingyi Zheng, Branda Hu, Stephen W. Hildreth, Robert Parkhill, William Warren
Publikováno v:
SLAS Technology. 21:287-296
The hemagglutination inhibition (HAI) assay quantifies the level of strain-specific influenza virus antibody present in serum and is the standard by which influenza vaccine immunogenicity is measured. The HAI assay endpoint requires real-time monitor
Autor:
Helene Janosczyk, Mark Boaz, Linda Starr-Spires, Gustavo H. Dayan, Stephen W. Hildreth, Seema Garg, Stacy Yost
Publikováno v:
Trials in Vaccinology, Vol 3, Iss C, Pp 127-133 (2014)
The CYD tetravalent dengue vaccine candidate is being evaluated for protective efficacy against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to confirm dengue cases was evaluated prior to Phase 3 trials. During a Phase
Autor:
John B. Robbins, A. Morris, Bruce D. Meade, Nicole Guiso, Stephen W. Hildreth, ChrisAnna M. Mink, Nancy E. Messonnier, Dorothy K.L. Xing, Drusilla L. Burns, L. Han, Kathryn M. Edwards, Maria Lucia Tondella, L. Hueston, James D. Cherry, Conrad P. Quinn, Erik L. Hewlett, M. Powell, C. H. Wirsing Von König, Jan Poolman, F. Lynn, George M. Carlone, Anna Giammanco
Publikováno v:
Vaccine
Vaccine, vol 27, iss 6
Vaccine, vol 27, iss 6
An international meeting on Bordetella pertussis assay standardization and harmonization was held at the Centers for Disease Control and Prevention (CDC), Atlanta, GA, 19-20 July 2007. The goal of the meeting was to harmonize the immunoassays used fo
Autor:
Edward B. Lewin, Peter R. Paradiso, Stephen W. Hildreth, Hogerman Deborah A, Dan J. Speelman, Joseph Oren, David H. Smith
Publikováno v:
The Pediatric Infectious Disease Journal. 13:792-797
A subunit vaccine for respiratory syncytial virus (RSV) consisting of purified fusion glycoprotein (designated PFP-1) was tested in children 24 to 48 months old. Two doses of 20 micrograms (n = 13) and 50 micrograms (n = 10) were compared with a sali
Autor:
Robert C. Welliver, Stephen W. Hildreth, Deborah A. Hogerman, Debra A. Tristram, Peter R. Paradiso
Publikováno v:
Vaccine. 12:551-556
In a previous study, children 18 to 36 months of age and seropositive for respiratory syncytial virus (RSV) were vaccinated with an RSV subunit vaccine (PFP-1) consisting of the viral fusion protein. Vaccines developed substantial increases in anti-f
Autor:
Denise J. Hahn, Stephen W. Hildreth, Dan J. Speelman, Gerald E. Hancock, Karen McQueen, Subramonia Pillai
Publikováno v:
Vaccine. 12:267-274
We have investigated the efficacy of vaccination with the purified fusion (F) protein of respiratory syncytial virus (RSV) on aluminium hydroxide adjuvant in Balb/c mice. The purpose of the study was to define the role of the local pulmonary mononucl
Autor:
Séverine Coddens, Brian D. Plikaytis, Bruce D. Meade, Michael T. Rock, Aditi Kapasi, Garvin S. Bixler, Monte D. Martin, Nancy E. Messonnier, Charles Jones, Lucia C. Pawloski, Kathryn M. Edwards, Maria Lucia Tondella, Sandra M. Yoder, Stephen W. Hildreth, Valérie Haezebroeck, Françoise Fievet-Groyne
Publikováno v:
Clinical and vaccine immunology : CVI. 19(1)
In an effort to improve the reliability and reproducibility of serological assays forBordetella pertussis, a collaborative study was conducted to compare four different sources of pertussis toxin (PT) as coating antigens in the immunoglobulin G (IgG)
Autor:
Philip R. Wyde, Dan J. Speelman, Stephen W. Hildreth, Alan M. Jewell, Mark W. Ambrose, Pedro A. Piedra, William L. Castleman
Publikováno v:
Vaccine. 11:1415-1423
The specificity of viral antigens in the formalin-inactivated, alum-precipitated respiratory syncytial virus (FI-RSV) vaccine in augmenting the pulmonary inflammatory response was evaluated. Cotton rats were immunized with a FI-RSV vaccine derived fr
Autor:
Hogerman Deborah A, Robert C. Welliver, D. A. Tristram, Peter R. Paradiso, Stephen W. Hildreth, C. K. Mohar
Publikováno v:
Journal of Infectious Diseases. 167:191-195
Twenty-six children (aged 18-36 months) previously hospitalized for respiratory syncytial virus (RSV) infection were randomized to receive 50 micrograms of an RSV subunit vaccine composed primarily of F glycoprotein or saline placebo by intramuscular
Publikováno v:
Vaccine. 9:231-237
The region of the fusion glycoprotein of respiratory syncytial virus which reacts with a neutralizing and fusion inhibiting monoclonal antibody, was mapped using a deductive method derived from analysis of Western blot reactivity of proteolytic fragm